leisure time -WSS

leisure time

author：comprehensive 2025-09-06 04:51:25 - browse：91

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： CDC's new outbreak response network to include Northeastern

WSS

Microbiome research is starting to find links to chronic diseases

Drug for rare kidney disease narrowly misses mark in clinical trial

Ukraine and a new approach to mental health in war

Changes to biosimilar regulatory framework must prioritize patients

STAT's guide to the next generation of CAR

In areas with more Black doctors, Black people live longer

leisure time

leisure time

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ask STAT: What do you want to know about ChatGPT in medicine?

Cancer drug shortages should be causing more outrage

Senators: Long

The high cost of giving birth even with insurance

Why we need to separate burnout from moral injury in health care

In Memoriam: Notable people who died in 2023

Cloning humans is technically possible. It's curious no one has tried

The high cost of giving birth even with insurance

How AI helped researchers track recovery from depression

focus

Second xenotransplant done with gene

STAT's guide to the next generation of CAR

CommonSpirit Health keeps growing, even as it loses money

Biotech lab space demand falls sharply

Intarcia’s device

Senate HELP committee spars over health care workforce policies

leisure time

knowledge

explore

explore